Bioeconomy — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Parse Biosciencesparsebiosciences.comSeries A · Jan 2021 · $7M

Parse Biosciences develops instrument-free single cell sequencing based on split-pool combinatorial barcoding, letting labs run scalable single cell experiments using only a pipette and common lab equipment.

BiotechDeep TechHealthtech

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.